Volume | 506,867 |
|
|||||
News | - | ||||||
Day High | 234.57 | Low High |
|||||
Day Low | 230.025 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Becton Dickinson and Company | BDX | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
232.33 | 230.025 | 234.57 | 234.36 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
16,625 | 506,867 | $ 232.97 | $ 118,087,116 | - | 229.395 - 287.32 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:32:57 | 3 | $ 234.325 | USD |
Becton Dickinson (BDX) Options Flow Summary
Becton Dickinson and Company Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
67.5B | 288.90M | - | 19.37B | 1.42B | 4.93 | 47.40 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Becton Dickinson News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BDX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 230.74 | 236.175 | 229.395 | 233.41 | 1,047,233 | 3.63 | 1.57% |
1 Month | 243.27 | 248.42 | 229.395 | 239.47 | 1,068,501 | -8.90 | -3.66% |
3 Months | 237.96 | 248.42 | 229.395 | 239.59 | 1,374,994 | -3.59 | -1.51% |
6 Months | 255.58 | 262.23 | 229.395 | 239.36 | 1,521,916 | -21.21 | -8.30% |
1 Year | 261.59 | 287.32 | 229.395 | 249.96 | 1,346,126 | -27.22 | -10.41% |
3 Years | 255.99 | 287.32 | 215.90 | 248.84 | 1,290,687 | -21.62 | -8.45% |
5 Years | 227.87 | 287.32 | 197.75 | 247.61 | 1,380,878 | 6.50 | 2.85% |
Becton Dickinson Description
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business. |